The Mini-Balance Evaluation Systems Test (Mini-BESTest)  by Potter, Kirsten & Brandfass, Kathi
Journal of Physiotherapy 61 (2015) 225
J o u rn a l o f
PHYSIOTHERAPY
journal homepage: www.e lsev ier .com/ locate / jphysAppraisal Clinimetrics
The Mini-Balance Evaluation Systems Test (Mini-BESTest)SummaryTheBalance Evaluation SystemsTest1 (BESTest)was developed to
identify the postural control system(s) that underly poor functional
balance, enabling physiotherapists to target treatment to a person’s
speciﬁcbalancedeﬁcit. TheBESTest consists of36 itemsgrouped into
six subsections: biomechanical constraints, stability limits/verticali-
ty, transitions/anticipatory postural control, reactive postural
control, sensory orientation and stability in gait. A limitation of
the BESTest is the time to administer it (30 to 45minutes). Therefore,
a shorter version of the BESTestwas developed via a Rasch analysis –
the Mini-Balance Evaluation Systems Test2 (Mini-BESTest). The
Mini-BESTest includes four subscales: transitions/anticipatory pos-
tural control, reactive postural control, sensory orientation and
stability in gait. Each item is rated on a three-point ordinal scale
(0 = severe to 2 = normal). Variations in the literature exist between
the number of items (14 versus 16) andmaximumpoints attainable
(24 versus 32). King and Horak3 clariﬁed this, stating that the Mini-
BESTest consists of 14 items,with amaximumscore of 28points. The
Mini-BESTest takes 10 to 15 minutes to administer.
Reliability and validity: With one exception,4 the reliability of
the Mini-BESTest is excellent to good, with ICC values >0.90 for
people with mixed diagnoses,5,6 stroke7 and Parkinson’s disease.8
The Mini-BEST test is reported to have high content validity.2
Multiple studies have demonstrated its criterion-related validi-
ty.5,7–11 Strong and statistically signiﬁcant correlations exist
between theMini-BESTest and the BESTest in Parkinson’s disease,8
and to other balance and gait measures for people with various
conditions, including the Timed Up-and-Go test and the Berg
Balance Scale.3,5,9 Weaker correlations exist between the Mini-http://dx.doi.org/10.1016/j.jphys.2015.04.002
1836-9553/ 2015 Australian Physiotherapy Association. Published by Elsevier B.V. AlBESTest and self-report measures of balance conﬁdence in people
with Parkinson’s disease and stroke.7,9,11With the exception of one
study,11 evidence exists to support the discriminative validity of
the Mini-BESTest. It can discriminate between fallers versus non-
fallers in people with various neurological conditions;6–8,10,12,13
people with Parkinson’s disease with balance deﬁcits versus
without balance deﬁcits;10 neurologic versus control subjects;6,7
and high versus low-functioning stroke survivors.14 Studies
indicate that the Mini-BESTest can predict falls in people with
stroke7 (cut-off score = 17.5/28) and Parkinson’s disease.8,12,13,15
Cut-off scores for people with Parkinson’s disease have varied,
including 19/28,13 20/328,12,15 and 23/32.8 Overall, the Mini-
BESTest appears to have acceptable sensitivity and speciﬁcity for
predicting fall risk in stroke and Parkinson’s disease.
Responsiveness: Two studies have examined the responsive-
ness of the Mini-BESTest. Tsang et al7 concluded that the minimal
detectable change score is 3.0 for individuals with stroke. In a
mixed population of people with imbalance, Godi et al5 concluded
that the minimally important change score is four points.
Floor and ceiling effects:With the exceptionofone studyof low-
functioning stroke survivors,14 the Mini-BESTest lacks a signiﬁcant
ﬂoor effect.2,5,7 Studies have indicated the lack of a ceiling effect in
people with various conditions and levels of severity.2,5,7,10,14
Normative values: Mini-BESTest scores decrease with age and
there is a signiﬁcant difference across age groups.16 For various age
groups, themean scores (SD) are: ages 50 to 59: 26.3/28 (1.1); ages
60 to 69: 24.7/28 (2.2); ages 70 to 79: 21.0/28 (3.1); and ages 80 to
89: 19.6/28 (4.2).CommentaryThe Mini-BESTest is a measure of balance and gait that is
appropriate for people with imbalance and various neurological
conditions. It was developed based on sound psychometric
principles and it has high clinical utility. Therapists have found
it easy to learn and feel that it provides relevant and valuable
information that is consistent with functional level.11 It is available
at no cost at http://www.bestest.us. Equipment is readily available
at most clinical settings, and it takes little time to administer and
score. The Mini-BEStest is reliable and able to predict falls. Lack of
ceiling and ﬂoor effects indicate it is appropriate for a wide variety
of people. Responsiveness and normative data exist to assist in goal
setting and determining treatment effectiveness.
Limitations of the Mini-BESTest include: variations in the
literature about scoring, a ﬂoor effect for lower-functioning people
and limited data from some populations. Administration may require
twotherapists, especially forpeoplewithsigniﬁcantphysicalorcognitive
impairments.11 Researchers have suggested that[12_TD$DIFF], used alone, it may not
be sufﬁcient to develop a comprehensive balance intervention.11,14
In summary, theMini-BESTest is a reliable, valid and responsive
measure that has high clinical utility. It assesses four aspects of
dynamic balance and is likely to have wide applicability to many
people with imbalance and neurological conditions[13_TD$DIFF].Provenance: Invited. Not peer-reviewed.
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